| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | KYPHA INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R43DK109870 | Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials | 000 | 1 | NIH | 11/17/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $218,241 ) |
| | 2016 | 2016 | KYPHA INC | 4320 FOREST PARK AVENUE | SAINT LUIS | MO | 63108 | | USA | R43DK109870 | Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials | 001 | 1 | NIH | 6/28/2016 | $218,241 |
| | 2016 | 2016 | KYPHA INC | 4320 FOREST PARK AVENUE | SAINT LUIS | MO | 63108 | | USA | R43DK109870 | Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials | 000 | 1 | NIH | 6/13/2016 | $218,241 |
| | 2016 | 2016 | KYPHA INC | 4320 FOREST PARK AVENUE | SAINT LUIS | MO | 63108 | | USA | R43DK109870 | Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials | 001 | 1 | NIH | 6/28/2016 | -$218,241 |
|
| Issue Date FY: 2011 ( Subtotal = $273,487 ) |
| | 2011 | 2011 | KENTUCKY PHARMACEUTICALS | 201 EAST JEFFERSON STREET | LOUISVILLE | KY | 40202 | JEFFERSON | USA | R43EY021438 | NANOCOMPOSITE IMAGING SYSTEM FOR THE EYE | 000 | 1 | NIH | 6/14/2011 | $273,487 |
| | 2011 | 2009 | KENTUCKY PHARMACEUTICALS | 201 EAST JEFFERSON STREET | LOUISVILLE | KY | 40202 | JEFFERSON | USA | R42EY017518 | TARGETING DRUG DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 000 | 4 | NIH | 6/30/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $591,670 ) |
| | 2010 | 2010 | KENTUCKY PHARMACEUTICALS | 201 EAST JEFFERSON STREET | LOUISVILLE | KY | 40202 | JEFFERSON | USA | R43HL103378 | DEVELOPMENT LATERAL FLOW ASSAY | 000 | 1 | NIH | 4/7/2010 | $199,998 |
| | 2010 | 2009 | KENTUCKY PHARMACEUTICALS | 201 EAST JEFFERSON STREET | LOUISVILLE | KY | 40202 | JEFFERSON | USA | R42EY017518 | TARGETING DRUG DELIVERY NANOPARTICLES TO SITES OF INFLAMMATION | 001 | 4 | NIH | 4/19/2010 | $391,672 |
|
|
